UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of ~~January~~February 2026

Commission File Number: 001-42795

DarkIris Inc.

(Registrant’s Name)

6/F, Cheong Sun Tower

No. 118 Wing Lok Street

Sheung Wan, Hong Kong

(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

~~Darkiris~~Submission ~~Inc.~~of ~~(the~~Matters ~~“Company”), today announced~~ to ~~hold the Annual Shareholders’ Meeting at 10:00~~ a~~.m.~~ onVote February 13, 2026 (local time) or 9:00 p.m. on February 12, 2026 (Eastern Time) at 6/F, Cheong Sun Tower, No. 118 Wing Lok Street, Sheung Wan, Hong Kong. The matters to be voted on at the meeting are set forth in the Company’s Form 6-K filed with the U.S. Securities and Exchange Commission on January 27, 2026. Shareholders of ~~record~~Security ~~on January 20, 2026 will be eligible to vote at this meeting~~Holders.

2On February 13, 2026, Darkiris Inc. (the “Company”) held the Company’s annual general meeting of shareholders (the “Annual Meeting”) at 10:00 a.m. local time at 6/F, Cheong Sun Tower, No. 118 Wing Lok Street, Sheung Wan, Hong Kong. Seven items of business were acted upon by the Company’s shareholders at the Annual Meeting, each of which was approved by the shareholders. The voting results were as follows:

~~EXHIBIT~~Proposal ~~INDEX~~No. 1.

Exhibit 99.1	-	Notice of Annual General Meeting of Shareholders of DarkIris Inc. (the “2026 AGM”)
Exhibit 99.2	-	Form of Proxy for the 2026 AGM

RESOLVED as an ordinary resolution that Hong Zhifang be re-appointed as a director of the Company, serving a term expiring at the next annual meeting of shareholders or until their successors are duly elected and qualified, subject to earlier death, resignation, or removal, with immediate effect.

For				Against				Abstain
	114,155,217.64				65,526				92

~~SIGNATURES~~Proposal 2:

RESOLVED as an ordinary resolution that Hong Yuanfang be re-appointed as a director of the Company, serving a term expiring at the next annual meeting of shareholders or until their successors are duly elected and qualified, subject to earlier death, resignation, or removal, with immediate effect.

For				Against				Abstain
	114,155,217.64				65,526				92

Proposal 3:

RESOLVED as an ordinary resolution that Ng Chee Jiong be re-appointed as a director of the Company, serving a term expiring at the next annual meeting of shareholders or until their successors are duly elected and qualified, subject to earlier death, resignation, or removal, with immediate effect.

For				Against				Abstain
	114,157,573.64				63,126				136

Proposal 4:

RESOLVED as an ordinary resolution, that Law Chee Hui be re-appointed as a director of the Company, serving a term expiring at the next annual meeting of shareholders or until their successors are duly elected and qualified, subject to earlier death, resignation, or removal, with immediate effect.

For				Against				Abstain
	114,155,217.64				65,526				92

Proposal 5:

RESOLVED as an ordinary resolution that Li Feng Lin be re-appointed as a director of the Company serving a term expiring at the next annual meeting of shareholders or until their successors are duly elected and qualified, subject to earlier death, resignation, or removal, with immediate effect.

For				Against				Abstain
	114,157,073.64				63,670				92

Proposal 6:

RESOLVED as an ordinary resolution that the appointment of Enrome LLP as auditor of the Company for the fiscal year ending September 30, 2025 be ratified, confirmed and adopted.

For				Against				Abstain
	114,170,123.64				49,695				1,017

Proposal 7:

RESOLVED as an ordinary resolution that

(i) a share consolidation of all of the authorized, issued, and outstanding Class A ordinary shares and Class B ordinary shares of the Company (collectively, the “Shares”) be and is hereby approved at a ratio of not less than two to one (2:1) and not more than two hundred and fifty to one (250:1) (the “Range”), with the exact ratio to be set at a whole number within this Range to be determined by the board of directors of the Company (the “Board of Directors”) in its sole discretion at any one time or multiple times during a period of up to three (3) years after the conclusion of the Annual Meeting, in each case, at such consolidation ratio and effective time as the Board of Directors may determine in its sole discretion and announced by the Company (together, the “Share Consolidations”, and each, a “Share Consolidation”); provided however, that the accumulated consolidation ratio for any and all such Share Consolidations shall be no less than 2:1 nor greater than 250:1, with such consolidated Shares having the same rights and being subject to the same restrictions (save as to nominal value) as the existing Shares of each class as set out in the Company’s current amended and restated memorandum and articles of association;

(ii) no fractional Shares be issued in connection with any Share Consolidation and, in the event that a Shareholder would otherwise be entitled to receive a fractional Share upon a Share Consolidation, the directors be and are hereby authorized to settle as they consider expedient any difficulty which arises in relation to the Share Consolidation, including but without prejudice to the generality of the foregoing capitalizing all or any part of any amount for the time being standing to the credit of any reserve or fund of the Company (including its share premium account and profit and loss account) whether or not the same is available for distribution and applying such sum in paying up unissued Shares to be issued to shareholders of the Company to round up any fractions of Shares issued to or registered in the name of such shareholders of the Company following or as a result of the Share Consolidation; and

any one director or officer of the Company be and is hereby authorized for and on behalf of the Company to do all such other acts or things necessary or desirable to implement, carry out, and give effect to the Share Consolidation(s), if and when deemed advisable by the Board of Directors, in its sole discretion.

For				Against				Abstain
	113,959,665.13				261,153.52				17

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: February 13, 2026
	DarkIris Inc.
	By:	/s/ Hong Zhifang
	Name:	Hong Zhifang n
Date: January 27, 2026	Title:	Chief Executive Officer
	Title:	Chief Executive Officer

Filing Compare · DarkIris Inc.